OMRON Healthcare Exceeds 400M Blood Pressure Monitors Sold
– Reinforcing Commitment to Preventive Cardiovascular and Home Blood Pressure Monitoring – KYOTO, Japan, Sept. 29, 2025 /PRNewswire/ — OMRON HEALTHCARE Co., Ltd., a global leader in innovative medical equipment for preventive healthcare, announced that cumulative worldwide sales of OMRON blood pressure monitors (BPMs) have exceeded 400 million units. This landmark achievement underscores the company’s longstanding […]
OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its position as a critical player in the global push for commercially viable sustainable aviation fuel (SAF). Series B investors include IAGi Ventures (the dedicated corporate venturing arm of the International Airlines Group), Safran Corporate Ventures, and Orlen VC alongside re-investment from world-class Series A […]
Premio Yidan 2025: destaca a los creadores de cambios que promueven la alfabetización en sistemas complejos
-El Premio Yidan 2025 destaca a los creadores de cambios que promueven la alfabetización en sistemas complejos y la educación multilingüe HONG KONG, 29 de septiembre de 2025 /PRNewswire/ — Yidan Prize Foundation, una organización filantrópica global, ha anunciado a los galardonados con el Premio Yidan 2025. El profesor Uri Wilensky y Mamadou Amadou Ly […]
De la start-up à l’entreprise d’envergure mondiale : Holafly franchit la barre des 500 millions de dollars
DUBLIN, 29 septembre 2025 /PRNewswire/ — Holafly, le pionnier mondial de l’eSIM, a annoncé aujourd’hui avoir dépassé les 500 millions de dollars de recettes cumulées depuis la pandémie, une étape qui met en lumière son évolution remarquable d’une start-up à une entreprise de grande envergure florissante qui façonne l’avenir de la technologie du voyage. Continue […]
Holafly supera los 500 millones de dólares en ingresos acumulados y prevé batir su récord histórico en 2025
DUBLÍN, 29 de septiembre de 2025 /PRNewswire/ — Holafly, la scale-up multinacional que ofrece una alternativa al roaming tradicional a través de eSIMs, ha generado más de 500 millones de dólares en ingresos desde el fin de la pandemia de COVID-19, impulsada por el fuerte crecimiento en mercados clave y la adopción generalizada de la […]
Milbank LLP To Host Call for Unsecured Bondholders of Braskem S.A.
NEW YORK, Sept. 29, 2025 /PRNewswire/ — Milbank LLP has been analyzing recent developments implicating unsecured creditors of Braskem S.A., including the company’s announcement that it has engaged financial and legal advisors to support the company in evaluating economic and financial alternatives to optimize its capital structure. Given its extensive familiarity with Braskem’s bank and bond […]
Education in Motion launches EiM Education Advisory Board
Leading thinkers from academia, policy, and industry to explore bold ideas on the future of learning SINGAPORE, Sept. 29, 2025 /PRNewswire/ — Education in Motion (EiM), a leading global education group, today announced the launch of its EiM Education Advisory Board, a pioneering initiative designed to advance thought leadership and innovation in education worldwide. Formed […]
New Agricultural Practices in Xinjiang: More Smart Technologies, a Happier Life
BEIJING, Sept. 28, 2025 /PRNewswire/ — A news report from China.org.cn on the technological application in Xinjiang’s agriculture: To cultivate a cotton field of 3,000 mu, equivalent to about 280 standard football pitches, how many farmers are needed? Continue Reading New Agricultural Practices in Xinjiang: More Smart Technologies, a Happier Life In Yuli County, Xinjiang, […]
Leqembi® approved for IV maintenance treatment in China
STOCKHOLM, Sept. 29, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer’s disease by the National Medical Products Administration (NMPA) in China. In January 2024, lecanemab was approved for […]
Leqembi® approved for IV maintenance treatment in China
STOCKHOLM, Sept. 29, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the treatment of early Alzheimer’s disease by the National Medical Products Administration (NMPA) in China. In January 2024, lecanemab was approved for […]